ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Services

IHH Healthcare Bhd.

Company Background

IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.

Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.

IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.

IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.

Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.

Business Summary

IHH Healthcare Bhd. operates as an investment holding company. The firm engages in the provision of healthcare services. It operates through the following geographical segments: Singapore, Malaysia, India, North Asia, Acibadem Holdings, IMU Health and PLife REIT. The company was founded on May 21, 2010 and is headquartered in Kuala Lumpur, Malaysia.

Financial Highlights

Dec 2020 MYRUSD
Revenue13,404.60M3,189.89M
Gross Profit2,709.70M644.82M
Operating income911.96M217.02M
Income before tax549.11M130.67M
Net income199.03M47.36M
EBITDA2,309.28M549.53M
Diluted EPS0.020.00
Dividends Per Share0.040.00
Total Assets44,534.26M11,071.28M
Total liabilities19,656.95M4,886.75M
Total equity21,739.81M5,404.55M
Operating cash flow2,085.16M496.20M
Currency in MYRCurrency in USD

Historical Data

 Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020
Revenue 10,021.88M 11,142.63M 11,520.93M 14,912.48M 13,404.60M
Gross Profit 2,657.91M 2,620.19M 2,884.52M 3,677.11M 2,709.70M
Operating income 1,227.74M 1,068.88M 1,203.24M 1,685.73M 911.96M
Income before tax 860.94M 1,162.33M 739.05M 968.61M 549.11M
Net income 612.35M 931.31M 541.84M 463.30M 199.03M
EBITDA 2,026.87M 2,046.96M 2,142.40M 3,041.22M 2,309.28M
Diluted EPS 0.07 0.11 0.06 0.05 0.02
Dividends Per Share 0.03 0.03 0.03 0.04 0.04
Total Assets 37,200.39M 38,925.48M 45,020.85M 45,111.62M 44,534.26M
Total liabilities 13,307.23M 15,183.41M 18,827.09M 19,175.82M 19,656.95M
Total equity 21,985.74M 21,890.16M 21,994.00M 22,339.53M 21,739.81M
Operating cash flow 1,730.45M 2,006.03M 1,562.71M 2,595.44M 2,085.16M
 Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020
Revenue 2,419.15M 2,591.60M 2,854.98M 3,599.45M 3,189.89M
Gross Profit 641.58M 609.41M 714.80M 887.55M 644.82M
Operating income 296.36M 248.60M 298.17M 406.88M 217.02M
Income before tax 207.82M 270.34M 183.14M 233.79M 130.67M
Net income 147.81M 216.60M 134.27M 111.82M 47.36M
EBITDA 489.26M 476.09M 530.90M 734.06M 549.53M
Diluted EPS 0.01 0.02 0.01 0.01 0.00
Dividends Per Share 0.00 0.00 0.00 0.00 0.00
Total Assets 8,292.55M 9,618.35M 10,894.33M 11,028.38M 11,071.28M
Total liabilities 2,966.39M 3,751.77M 4,555.86M 4,687.89M 4,886.75M
Total equity 4,900.96M 5,408.98M 5,322.20M 5,461.32M 5,404.55M
Operating cash flow 417.70M 466.57M 387.25M 626.46M 496.20M

Valuation Measures

Dec 2020
PER242.29
ROA0.44%
ROE0.90%
Operating margin6.80%
Profit margin1.48%

Key executives

  • CEO, MD & Non-Independent Executive Director: Chi-Keon Kelvin Loh
  • Group Chief Operating Officer: Sim Heng Joo Joe
  • Group Chief Financial Officer: Soon Teck Low
  • Group Head-Internal Audit: Audrey Huang
  • Vice President-Investor Relations: Penelope Koh

Shareholders

  • Mitsui & Co., Ltd. (32.9%)
  • Khazanah Nasional Bhd. (Investment Company) (26.0%)
  • Employees Provident Fund (9.9%)
  • Permodalan Nasional Bhd. (5.1%)
  • AYDINLAR MEHMET ALI (4.8%)
  • Kumpulan Wang Persaraan (3.0%)
  • Public Mutual Bhd. (1.7%)
  • Kuwait Investment Authority (Investment Management) (1.6%)
  • AYDINLAR FAMILY (1.1%)
  • The Vanguard Group, Inc. (1.0%)

Contact Details

Related Companies

  • Northern TK Venture Pte Ltd.
  • IHH Healthcare Bhd. (Singapore)
  • Centre For Digestive & Kidney Diseases India Pvt Ltd.
  • Acibadem Saglik Yatirimlari Holding AS
  • Indah Capital Ltd.
  • Shanghai Mai Kang Hospital Investment Management Co. Ltd.
  • Bodrum Tedavi Hizmetleri A.S
  • Integrated Healthcare Turkey Yatirimlari Ltd.
  • Gleneagles Development Pte Ltd.
  • Integrated Healthcare Holdings Ltd.
  • Acibadem Saglik Hizmetleri ve Ticaret AS
  • Pantai Holdings Sdn. Bhd.
  • Parkway Holdings Ltd.

Competitors

    Last Updated on 16 Apr, 2021

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

    Stay ahead with our exclusives on Asia;
    the most dynamic market in the world.

    Stay ahead with our exclusives on Asia

    Get trusted insights from experts within Asia itself.

    Get trusted insights from experts
    within Asia itself.

    Try 1 month for $0.99

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

    This is your last free article this month

    Stay ahead with our exclusives on Asia; the most
    dynamic market in the world
    .

    Get trusted insights from experts
    within Asia itself.

    Try 3 months for $9

    Offer ends January 31st

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to Nikkei Asia has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more